These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 5675489)

  • 1. Phenothiazines and diffuse melanosis.
    Greiner AC
    Agressologie; 1968; 9(2):219-24. PubMed ID: 5675489
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged treatment of psychotic states. (Over 1600 patients treated continuously 3 to 7 years).
    Goldman D
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:51-7. PubMed ID: 4970486
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognosis of eye complications caused by phenothiazines.
    Forrest FM; Snow HL
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:26-8. PubMed ID: 5672560
    [No Abstract]   [Full Text] [Related]  

  • 4. Schizophrenia-melanosis: cause or side-effect?
    Greiner AC; Nicolson GA
    Lancet; 1965 Dec; 2(7423):1165-7. PubMed ID: 4158914
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ocular involvement during prolonged treatment with neuroleptics].
    Nouri A; Cuendet JF
    Schweiz Med Wochenschr; 1968 Oct; 98(43):1708-11. PubMed ID: 4974196
    [No Abstract]   [Full Text] [Related]  

  • 6. [Observations on the body experience and motor behavior of schizophrenics during neuroleptic therapy].
    Vella G; Ciani N
    Osp Psichiatr; 1965; 33(4):481-90. PubMed ID: 4381125
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetes in chronic schizophrenia.
    Marinow A
    Dis Nerv Syst; 1971 Nov; 32(11):777-8. PubMed ID: 5131772
    [No Abstract]   [Full Text] [Related]  

  • 8. Schizophrenia melanosis. Iatrogenic--congenital defect?
    Grener AC
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:14-5. PubMed ID: 5676976
    [No Abstract]   [Full Text] [Related]  

  • 9. Some effects of mesoridazine (TPS-23) on chronic psychiatric patients.
    Douglas KW; Hindley JP; Kerin MT
    Dis Nerv Syst; 1967 Feb; 28(2):113-7. PubMed ID: 6021590
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluspirilene and pipothiazine undecylenate, two long-acting injectable neuroleptics. A double-blind controlled trial in residual schizophrenia.
    Vereecken JL; Tanghe A
    Psychiatr Neurol Neurochir; 1972; 75(2):117-27. PubMed ID: 5030483
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic results and complications in the use of lyogen in long-term schizophrenics].
    Kutsenok BM; Zolotnitskiĭ RI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(10):1578-83. PubMed ID: 5490156
    [No Abstract]   [Full Text] [Related]  

  • 12. Ocular effects of phenothiazine derivatives and reversibility.
    Mathalone MB
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences with thiothixene (navane) in chronic schizophrenia].
    Gann G
    Wien Med Wochenschr; 1968 Jan; 118(1):10-3. PubMed ID: 5668801
    [No Abstract]   [Full Text] [Related]  

  • 14. Sudden death and phenothiazines.
    Lancet; 1966 Oct; 2(7466):740. PubMed ID: 4162067
    [No Abstract]   [Full Text] [Related]  

  • 15. Ocular complications related to phenothiazines.
    Siddall JR
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:10-3. PubMed ID: 4876740
    [No Abstract]   [Full Text] [Related]  

  • 16. [Skin pigmentation caused by medications].
    S Afr Med J; 1967 Aug; 41(29):709-10. PubMed ID: 6051088
    [No Abstract]   [Full Text] [Related]  

  • 17. [Facial dyskinesias caused by phenothiazine derivatives].
    De Oya JC; Alvarez Prechous A; Del Río A; Noya M; Ansede A
    Rev Clin Esp; 1971 May; 121(4):357-60. PubMed ID: 5563111
    [No Abstract]   [Full Text] [Related]  

  • 18. [Post-neuroleptic late dyskinesia].
    Villeneuve A; Lavallée JC; Lemieux LH
    Laval Med; 1969 Nov; 40(9):832-7. PubMed ID: 5366584
    [No Abstract]   [Full Text] [Related]  

  • 19. "Miscellaneous" side effects during prolonged phenothiazine therapy.
    Zabors TE
    Wis Med J; 1967 Feb; 66(2):115-7. PubMed ID: 5342511
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ocular manifestations during treatment with phenothiazine derivatives].
    Ardouin M; Feuvrier YM; Delattre A
    Bull Soc Ophtalmol Fr; 1969 Mar; 69(3):395-401. PubMed ID: 5383905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.